Vivaldi Asset Management »

Tourmaline Bio shares owned by Vivaldi Asset Management

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by Vivaldi Asset Management from 13F filings

Historical chart of Vivaldi Asset Management investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by Vivaldi Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by Vivaldi Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $33M 696k 47.83

More positions owned by Vivaldi Asset Management

WNS HLDGS Equity (WNS)
Verona Pharma Equity (VRNA)
Veritex Hldgs Equity (VBTX)
Mr Cooper Group Equity
Cyberark Software Equity (CYBR)
Electronic Arts Equity (EA)
Aris Water Solutions Equity (ARIS)
Kellanova Equity (K)
Agriculture & Nat Sol Acq Equity (ANSC)
Tourmaline Bio Equity (TRML)
Avidxchange Holdings Equity (AVDX)
Aa Mission Acquisition Corp Equity (AAM)
Centurion Acquisition Corp Equity (ALF)
Merus N V Equity (MRUS)
Drugs Made In Amer Acqutn Equity (DMAA)

View all positions for Vivaldi Asset Management

Top funds holding Tourmaline Bio

venBio Select Advisor
QVT Financial
BlackRock
TCG Crossover Management
Pfizer
Vanguard Group
Fil
Magnetar Financial
Qiming U.S. Ventures Management
Vivaldi Asset Management
TIG Advisors
Vivo Capital
Alliancebernstein
Highland Capital Management Fund Advisors
Geode Capital Management

View all funds holding Tourmaline Bio